LifeVantage Formally Expands Its Global Operations to Hong Kong

LifeVantage Formally Expands Its Global Operations to Hong Kong

SALT LAKE CITY, Dec. 19, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation
(Nasdaq:LFVN), a company dedicated to helping people achieve healthy living
through a combination of a compelling business opportunity and scientifically
validated products, including its patented dietary supplement Protandim®, the
Nrf2 Synergizer®, today announced that following completion of extensive
market preparation including regulatory and legal review, it has expanded its
operations to Hong Kong.

"We are excited about our expansion into Hong Kong and reaffirm our commitment
to continued growth in a sustainable manner," said LifeVantage President and
CEO Douglas C. Robinson. "Historically, Asian markets, including Japan have
responded positively to our combined messages of healthy living and the
dynamic business opportunities represented by LifeVantage and its products. We
anticipate that with a population of seven million, Hong Kong will become an
important market for us."

LifeVantage's expansion into Hong Kong is a natural outgrowth of the Company's
global plan to grow its market presence in countries where its healthy living
message resonates. As one of the world's great financial centers with a
history of entrepreneurship, innovation and capitalism, LifeVantage is excited
about its entrance into the Hong Kong market. LifeVantage is officially
conducting business in Hong Kong by enrolling Independent Distributors and
shipping product. David Toda, President and Managing Director of Asia Pacific
will oversee the day-to-day operations of LifeVantage in Hong Kong.

"Our business opportunity and compensation plan have been developed by leading
minds in the industry," Robinson said. "We have high expectations as we offer
our motivating and rewarding compensation and recognition plan to the people
of Hong Kong, as we expand our operations in Asia."

About LifeVantage Corporation

LifeVantage (Nasdaq:LFVN), a leader in Nrf2 science and the maker of
Protandim®, the Nrf2 Synergizer® patented dietary supplement, is a science
based nutraceutical company. LifeVantage is dedicated to visionary science
that looks to transform wellness and anti-aging internally and externally with
products that dramatically reduce oxidative stress at the cellular level. The
Company was founded in 2003 and is headquartered in Salt Lake City, UT.

The LifeVantage Corporation logo is available at

Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.
Words and expressions reflecting optimism and satisfaction with current
prospects, as well as words such as "believe," "anticipates," "expects," look
forward to," "should" and variations thereof, identify forward-looking
statements, but their absence does not mean that a statement is not
forward-looking. Examples of forward-looking statements include, but are not
limited to, statements we make regarding our anticipated growth rate in Hong
Kong and the importance of the market. Such forward-looking statements are not
guarantees of performance and the Company's actual results could differ
materially from those contained in such statements. These forward-looking
statements are based on the Company's current expectations and beliefs
concerning future events affecting the Company and involve known and unknown
risks and uncertainties that may cause the Company's actual results or
outcomes to be materially different from those anticipated and discussed
herein. These risks and uncertainties include, among others, the Company's
inability to successfully expand our operations in existing and other markets
and thereafter manage our growth; the Company's ability to retain independent
distributors or to attract new independent distributors on an ongoing basis;
the Company's ability to expand its product offerings; violations of law or
our procedures by the Company's independent distributors; the potential for
third-party and governmental actions involving the Company's network marketing
efforts; the potential for product liability claims against the Company; the
risk that government regulators and regulations could adversely affect the
Company's business; future laws or regulations may hinder or prohibit the
production or sale of the Company's existing product and any future products;
unfavorable publicity could materially hurt the Company's business; the
Company's ability to access raw materials for its Products as it grows; and
the Company's ability to protect its intellectual property rights and the
value of its product. These and other risk factors are discussed in greater
detail in the Company's Annual Report on Form 10-K and its Quarterly Report on
Form 10-Q under the caption "Risk Factors," and in other documents filed by
the Company from time to time with the Securities and Exchange Commission. The
Company cautions investors not to place undue reliance on the forward-looking
statements contained in this document. All forward-looking statements are
based on information currently available to the Company on the date hereof,
and the Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after the date
of this document, except as required by law.

CONTACT: Investor Relations Contact:
         Cindy England (801) 432-9036
         Director of Investor Relations
         John Mills (310) 954-1105
         Senior Managing Director, ICR, LLC

company logo
Press spacebar to pause and continue. Press esc to stop.